Year |
Citation |
Score |
2023 |
Krueger ES, Griffin LE, Beales JL, Lloyd TS, Brown NJ, Elison WS, Kay CD, Neilson AP, Tessem JS. Bioavailable Microbial Metabolites of Flavanols Demonstrate Highly Individualized Bioactivity on In Vitro β-Cell Functions Critical for Metabolic Health. Metabolites. 13. PMID 37512508 DOI: 10.3390/metabo13070801 |
0.629 |
|
2022 |
Iglesias-Carres L, Krueger ES, Herring JA, Tessem JS, Neilson AP. Potential of Phenolic Compounds and Their Gut Microbiota-Derived Metabolites to Reduce TMA Formation: Application of an Fermentation High-Throughput Screening Model. Journal of Agricultural and Food Chemistry. PMID 35235743 DOI: 10.1021/acs.jafc.2c00247 |
0.527 |
|
2021 |
Krueger ES, Beales JL, Russon KB, Elison WS, Davis JR, Hansen JM, Neilson AP, Hansen JM, Tessem JS. Gut Metabolite Trimethylamine N-Oxide Protects INS-1 β-Cell and Rat Islet Function under Diabetic Glucolipotoxic Conditions. Biomolecules. 11. PMID 34944536 DOI: 10.3390/biom11121892 |
0.619 |
|
2021 |
Krueger ES, Lloyd TS, Tessem JS. The Accumulation and Molecular Effects of Trimethylamine N-Oxide on Metabolic Tissues: It's Not All Bad. Nutrients. 13. PMID 34445033 DOI: 10.3390/nu13082873 |
0.612 |
|
2021 |
Krueger ES, Beales JL, Elison WS, Tessem1 JS. Gut Metabolite Trimethylamine N-oxide Protects β Cell Insulin Secretion by Reducing Oxidative Stress and Maintaining Insulin Granule Formation Current Developments in Nutrition. 5: 57-57. DOI: 10.1093/CDN/NZAB033_057 |
0.358 |
|
2020 |
Krueger E, Austin M, Ekpo I, Beales J, Yang H, Nielson A, Tessem JS. Screening Phytochemicals for Alternative Diabetes Treatments The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05911 |
0.612 |
|
2020 |
Lloyd T, Griffin L, Krueger E, Beales J, Barlow A, Sheets J, Ekpo I, Ross M, Chandra P, Rathore A, Kay C, Neilson A, Tessem JS. Supplemental treatment options for diabetes: how flavanol metabolites improve β‐cell function The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05762 |
0.63 |
|
Show low-probability matches. |